Back to Newsroom

Accera Joins Alzheimer’s Association Research Roundtable

BROOMFIELD, Colo., Sept. 21, 2015 /PRNewswire/ — Accera, Inc., a clinical-stage biotechnology company developing therapies for central nervous system disorders, announced today that it has been invited to join the Alzheimer’s Association Research Roundtable. Participation in the Roundtable provides an opportunity for the company to advance Alzheimer’s disease research and drug development by sharing scientific knowledge with other major research organizations in the field. Accera executives will participate in Roundtable presentations and related subcommittee meetings, with a particular focus on the need for new treatments for Alzheimer’s disease.

Click here to read more